Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 32.40
-0.05 (-0.15%)
Jan 22, 2026, 10:37 AM CST
Synmosa Biopharma Revenue
Synmosa Biopharma had revenue of 1.54B TWD in the quarter ending September 30, 2025, with 7.95% growth. This brings the company's revenue in the last twelve months to 6.11B, up 13.64% year-over-year. In the year 2024, Synmosa Biopharma had annual revenue of 5.55B with 7.96% growth.
Revenue (ttm)
6.11B
Revenue Growth
+13.64%
P/S Ratio
2.66
Revenue / Employee
n/a
Employees
n/a
Market Cap
16.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.55B | 409.05M | 7.96% |
| Dec 31, 2023 | 5.14B | 754.13M | 17.19% |
| Dec 31, 2022 | 4.39B | 1.15B | 35.59% |
| Dec 31, 2021 | 3.23B | 196.67M | 6.47% |
| Dec 31, 2020 | 3.04B | 358.32M | 13.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grape King Bio | 10.40B |
| YungShin Global Holding | 8.37B |
| Standard Chemical & Pharmaceutical | 6.91B |
| TTY Biopharm Company | 6.50B |
| Formosa Laboratories | 4.90B |
| ScinoPharm Taiwan | 3.19B |
| Handa Pharmaceuticals | 1.62B |
| Center Laboratories | 1.57B |